KO'KRAK SARATONINI DAVOLASHDA NEONAD'YUVANT XIMIOTERAPIYANING SAMARADORLIGINI BAHOLASH: ANIQ BIR KLINIKADAGI DAVOLASH NATIJALARINI RETROSPEKTIV TAHLIL QILISH
Keywords:
ko‘krak saratoni, neoad’yuvant ximioterapiya, patologik to‘liq javob, retrospektiv tahlil, davolash samaradorligi.Abstract
Mazkur maqolada xususiy onkologik klinikada ko‘krak saratoni bilan og‘rigan bemorlarda neoad’yuvant ximioterapiyaning samaradorligi retrospektiv tahlil asosida baholandi. Tadqiqotda o‘sma hajmining kamayishi, patologik to‘liq javob (pCR) ko‘rsatkichi hamda davolash natijalari o‘rganildi. Olingan natijalar neoad’yuvant ximioterapiyaning klinik samaradorligini tasdiqlab, jarrohlik aralashuviga tayyorlashda muhim ahamiyatga ega ekanligini ko‘rsatdi. Shuningdek, turli biologik subtiplar kesimida davolash natijalarining farqlanishi qayd etildi. Tadqiqot natijalari ko‘krak saratonini kompleks davolashda neoad’yuvant yondashuvning ahamiyatini asoslaydi.
References
World Health Organization. Global Cancer Observatory: Breast Cancer Factsheet. Geneva: WHO; 2023.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Version 2024.
European Society for Medical Oncology. ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of early breast cancer. Ann Oncol. 2023.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Long-term outcomes for neoadjuvant chemotherapy in early breast cancer. Lancet. 2018.
Cortazar Pablo et al. Pathological complete response and long-term clinical benefit in breast cancer: pooled analysis. Lancet. 2014;384:164–172.
Slamon Dennis et al. Neoadjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med. 2011;365:1273–1283.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles published in IQRO — Scientific Methodological Journal are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
Authors retain copyright and grant the journal the right of first publication.
Users may read, download, copy, distribute, print, search, or link to the full texts of articles, provided that the original authors and the journal are properly cited.
Published materials may be used, distributed, and reproduced in any medium, provided that the original work is properly cited.



Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo